Results 11 to 20 of about 38,655 (210)

Worldwide epidemiologic factors in pemphigus vulgaris and bullous pemphigoid

Frontiers in Immunology, 2023
Autoimmune blistering diseases such as bullous pemphigoid (BP) and pemphigus vulgaris (PV) are complex, multifactorial, and polygenic diseases, whose exact pathogenesis is difficult to pinpoint.
M. Rosi-Schumacher, J. Baker, James Waris, K. Seiffert-Sinha, A. Sinha   +4 more
semanticscholar   +1 more source

Advancements in Bullous Pemphigoid Treatment: A Comprehensive Pipeline Update

American Journal of Clinical Dermatology, 2023
Bullous pemphigoid (BP) is a common autoimmune bullous disease affecting mainly the elderly, with rising incidence due to increased life expectancy. This disease is characterized by tense bullous lesions on normal or erythematous skin, accompanied by ...
Meropi Karakioulaki, K. Eyerich, A. Patsatsi   +2 more
semanticscholar   +1 more source

Updated S2 K guidelines for the management of bullous pemphigoid initiated by the European Academy of Dermatology and Venereology (EADV)

Journal of the European Academy of Dermatology and Venereology, 2022
Bullous pemphigoid (BP) is the most common autoimmune subepidermal blistering disease of the skin and mucous membranes. This disease typically affects the elderly and presents with itch and localized or, most frequently, generalized bullous lesions.
L. Borradori, N. van Beek, C. Feliciani, B. Tedbirt, E. Antiga, R. Bergman, B. Böckle, M. Caproni, F. Caux, N. S. Chandran, G. Cianchini, M. Daneshpazhooh, D. De, D. Didona, G. Di Zenzo, M. Dmochowski, K. Drenovska, J. Ehrchen, M. Goebeler, R. Groves, C. Günther, B. Horváth, M. Hertl, S. Hofmann, D. Ioannides, B. Itzlinger-Monshi, J. Jedlickova, C. Kowalewski, K. Kridin, Y. L. Lim, B. Marinović, A. Marzano, J. Mascaro, J. Meijer, D. Murrell, K. Patsatsi, C. Pincelli, C. Prost, K. Rappersberger, M. Sárdy, J. Setterfield, M. Shahid, E. Sprecher, K. Tasanen, S. Uzun, S. Vassileva, K. Vestergaard, A. Vorobyev, I. Vujic, G. Wang, K. Wozniak, S. Yaylı, G. Zambruno, D. Zillikens, E. Schmidt, P. Joly   +55 more
semanticscholar   +1 more source

Risk of Serious Infections in Patients with Bullous Pemphigoid: A Population-based Cohort Study

Acta Dermato-Venereologica, 2023
Patients with bullous pemphigoid are susceptible to serious infections, which are the leading cause of death in these patients. The aims of this population-based cohort study were to investigate the incidence and spectrum of serious infections in ...
Tsung-Hsien Chang, Chun-Ying Wu, Yun-Ting Chang, Ying-Syuan Lyu, Chen-Yi Wu   +4 more
doaj   +1 more source

Esophageal Bullous Pemphigoid

European Journal of Case Reports in Internal Medicine, 2022
Bullous pemphigoid is a rare autoimmune dermatologic disease that usually occurs in the elderly. Mucous membrane lesions occur in about 10–35% of patients and are almost always limited to the oral mucous membrane. Esophageal involvement is very rare (4% of cases) and usually presents with chest pain, dysphagia, and odynophagia, though patients are ...
Castelo Branco, Catarina, Fonseca, Tomás, Marcos-Pinto, Ricardo   +2 more
openaire   +4 more sources

Bilateral localized bullous pemphigoid in a young adult patient: A case report

SAGE Open Medical Case Reports, 2023
Bullous pemphigoid is the most common autoimmune subepidermal blistering disease, which typically presents in the elderly. Localized bullous pemphigoid is a rare variant of bullous pemphigoid, with only about 100 cases reported up to date. In this report,
Pedram Nourmohammadpour, Marwa Akhdar, Alireza Ghanadan, Amir Abbas Peymanfar, Fatemeh Saberi, Mahsa Keshavarz-Fathi   +5 more
doaj   +1 more source

Noninvasive Imaging Techniques as Modern Diagnostic Tools in Desquamative Gingivitis: Focus on RCM, OCT, and LC-OCT. [PDF]

Skin Res Technol
ABSTRACT Background Desquamative gingivitis is a clinical condition characterized by erythema, blisters, and erosions within the gingiva. It may be a manifestation of oral lichen planus or autoimmune bullous diseases, such as pemphigus vulgaris and mucous membrane pemphigoid. The identification of the cause of desquamative gingivitis typically involves
Fałkowska U, Durmaj A, Szwed C, Kurzeja M, Czuwara J, Olczak-Kowalczyk D, Rudnicka L, Olszewska M.   +7 more
europepmc   +2 more sources

Rituximab, Omalizumab, and Dupilumab Treatment Outcomes in Bullous Pemphigoid: A Systematic Review

Frontiers in Immunology, 2022
Background Bullous pemphigoid (BP) is the most common autoimmune subepidermal bullous disease of the skin. First-line treatment of systemic corticosteroids may cause serious adverse events.
Peng Cao, Wenjing Xu, Litao Zhang
semanticscholar   +1 more source

Efficacy and Safety of Dupilumab in Moderate-to-Severe Bullous Pemphigoid

Frontiers in Immunology, 2021
Background Bullous pemphigoid (BP) is an autoimmune blistering disorder that predominantly affects the elderly. As the main treatment for BP, systemic corticosteroids are often limited by their side effects.
Yihua Zhang, Qiu-Yun Xu, Lihong Chen, Jiawen Chen, Jing Zhang, Y. Zou, T. Gong, Chao Ji   +7 more
semanticscholar   +1 more source

Bullous pemphigoid

Indian Journal of Dermatology, Venereology, and Leprology, 2011
Bullous pemphigoid (BP) is a relatively common autoimmune vesicobullous disease encountered in India. It is a subepidermal bullous disorder most commonly seen in the elderly and manifests as tense blisters on urticarial base, predominantly over flexures, and is associated with pruritus.
Sujay, Khandpur, Parul, Verma
openaire   +3 more sources